Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
DANBURY, Conn., Nov. 27, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Jennifer Good, President and Chief Executive Officer of Penwest, will be presenting at...
-
DANBURY, Conn., Nov. 2, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced its financial results for the third quarter and nine months ended September 30, 2007. Third...
-
DANBURY, Conn., Oct. 30, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Jennifer Good, President and Chief Executive Officer of Penwest, is scheduled to...
-
DANBURY, Conn., Oct. 26, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) announced today that it has completed patient enrollment in its Phase IIa clinical trial of nalbuphine...
-
DANBURY, Conn., Oct. 22, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Friday, November 2, 2007, at 11:00 a.m. EDT to review its financial...
-
DANBURY, Conn., Oct. 3, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Jennifer Good, President and Chief Executive Officer of Penwest, is scheduled to present...
-
DANBURY, Conn., Oct. 3, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced the issuance by the U.S. Patent and Trademark Office (USPTO) of U.S. Patent No. 7276250,...
-
DANBURY, Conn., Sept. 10, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Jennifer Good, President and Chief Executive Officer of Penwest, is scheduled to...
-
DANBURY, Conn., Sept. 7, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has signed a research and development agreement with Otsuka Pharmaceutical Co., Ltd....
-
DANBURY, Conn., July 27, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced its financial results for the second quarter and six months ended June 30, 2007. Second...